Eleonora Allocati
Impact in
-
- Antibiotic Use and Resistance
-
- Biosimilars and Bioanalytical Methods
Papers in
-
- Biosimilars and Bioanalytical Methods 6
-
- Health Systems, Economic Evaluations, Quality of Life 5
- Pharmaceutical Economics and Policy 4
- Co-authors
- Brian Godman (6 shared papers)Rita Banzi (5 shared papers)Silvio Garattini (3 shared papers)Chiara Gerardi (12 shared papers)Marco Gobbi (3 shared papers)Attilio Guarini (8 shared papers)Carla Minoia (8 shared papers)Evelien Moorkens (2 shared papers)
- Journals
- Cancers (7 papers)Generics and Biosimilars Initiative Journal (2 papers)Scientific Reports (1 paper)Obesity Reviews (1 paper)Journal of Medical Economics (1 paper)
- Partner nations
- ItalyUnited KingdomSouth Africa
In The Last Decade
Eleonora Allocati
19 papers receiving 161 citations
Peers
Comparison fields: 5 of 49
- Applied Microbiology and Biotechnology 11
- Immunology 57
- Economics and Econometrics 30
- Radiology, Nuclear Medicine and Imaging 22
- Oncology 17
Countries citing papers authored by Eleonora Allocati
This map shows the geographic impact of Eleonora Allocati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleonora Allocati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleonora Allocati more than expected).
Fields of papers citing papers by Eleonora Allocati
This network shows the impact of papers produced by Eleonora Allocati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleonora Allocati. The network helps show where Eleonora Allocati may publish in the future.
Co-authors
The 25 scholars most cited alongside Eleonora Allocati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 34 | |
| 2 | 2022 | 25 | |
| 3 | 2021 | 21 | |
| 4 | 2021 | 12 | |
| 5 | 2020 | 9 | |
| 6 | 2021 | 9 | |
| 7 | 2019 | 9 | |
| 8 | 2021 | 8 | |
| 9 | 2021 | 6 | |
| 10 | 2021 | 6 | |
| 11 | 2022 | 5 | |
| 12 | 2020 | 5 | |
| 13 | 2022 | 5 | |
| 14 | 2021 | 4 | |
| 15 | 2023 | 3 | |
| 16 | 2021 | 2 | |
| 17 | 2024 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2020 | 1 | |
| 20 | 2025 | 0 |
About Eleonora Allocati
Eleonora Allocati is a scholar working on Immunology, Economics and Econometrics, Surgery, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine, having authored 20 papers that have together received 166 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Pharmaceutical Economics and Policy (4 papers), Cancer-related cognitive impairment studies (3 papers), Thyroid and Parathyroid Surgery (2 papers), Cardiac Imaging and Diagnostics (1 paper), Cardiac, Anesthesia and Surgical Outcomes (1 paper) and Pharmaceutical industry and healthcare (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (11 citations), Immunology (57 citations), Economics and Econometrics (30 citations), Radiology, Nuclear Medicine and Imaging (22 citations) and Oncology (17 citations). Eleonora Allocati has collaborated with scholars based in Italy, United Kingdom and South Africa. Frequent co-authors include Brian Godman, Rita Banzi, Silvio Garattini, Chiara Gerardi, Marco Gobbi, Attilio Guarini, Carla Minoia, Evelien Moorkens, Vitaliana De Sanctis and Vanda Marković‐Peković. Their work appears in journals such as Cancers, Generics and Biosimilars Initiative Journal, Scientific Reports, Obesity Reviews and Journal of Medical Economics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.